Beijing, China

Rong Zhou

This inventor holds 7 USPTO granted patents and 11 published patent applications and 3 EPO patents. Top assignees: Boe Technology Group, Fuzhou Boe Optoelectronics Technology Co., Ltd., Novo Nordisk A/s. Active years: 2016-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rong Zhou. Retrieved from https://idiyas.com/inventor/rong-zhou-3c29hu6n

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 7 

% Patents Active = 71.4

 

Average Co-Inventor Count = 6.7

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2016-2026

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Rong Zhou: Innovator in Display Technology and Coagulation Research

Introduction

Rong Zhou is a prominent inventor based in Beijing, China. He has made significant contributions to the fields of display technology and medical research, holding a total of 7 patents. His innovative work has garnered attention in both academic and industrial circles.

Latest Patents

Rong Zhou's latest patents include advancements in array substrates and procoagulant antibodies. One of his notable inventions is an array substrate that features a driving circuit arranged on a base substrate. This driving circuit includes a pull-up node control circuit, a first pull-down node control circuit, and an output circuit. The pull-up node control circuit manages the potential of the pull-up node, while the first pull-down node control circuit facilitates the writing of a first control voltage into the first pull-down node. The output circuit is responsible for controlling the driving signal output terminal to emit a driving signal based on the pull-up node's potential. Additionally, the array substrate incorporates a first conductive portion that is electrically connected to the first control voltage line. Another significant patent involves improved procoagulant antibodies, which include bispecific antibodies capable of binding to coagulation Factor IX and promoting its activation. This invention has potential applications in treating coagulopathies such as hemophilia A.

Career Highlights

Throughout his career, Rong Zhou has worked with notable companies, including Novo Nordisk A/S and Fujitsu Corporation. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in technology and healthcare.

Collaborations

Rong Zhou has collaborated with esteemed colleagues, including Karina Thorn and Bjarne Gram Hansen. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise.

Conclusion

Rong Zhou's contributions to display technology and coagulation research highlight his innovative spirit and dedication to advancing science. His patents reflect a commitment to solving complex problems and improving lives through technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…